Product Reports Resources Pricing Login Book a demo

PhoreMost

Biotech & Life Sciences · Pampisford, United Kingdom · Founded 2014

A new-model drug discovery company based in Cambridge, UK MoreLess

PhoreMost is a biotechnology company focused on expanding the druggable space through its innovative drug target identification platform. The company operates in the pharmaceutical and biotechnology markets, primarily serving clients involved in drug discovery and development. PhoreMost collaborates with leading organizations, such as Oxford Biomedica and XtalPi, to discover and develop next-generation therapies, including targeted protein degradation and gene therapy solutions. The business model revolves around partnerships and collaborations, leveraging its platform to identify first-in-class drug targets in areas of high unmet need, particularly in oncology and neurodegenerative disorders. PhoreMost generates revenue through research collaborations, licensing agreements, and milestone payments from its partners. The company is driven by a team of scientists and biotechnology professionals, led by an experienced management team passionate about advancing medical science.

Keywords: drug target identification, biotechnology, oncology, neurodegenerative disorders, gene therapy, AI collaboration, protein degradation, drug discovery, partnerships, licensing.

Company overview

PhoreMost company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2014
Headquarters
Pampisford, United Kingdom
Employees
33
Open positions
None listed
Dealroom signal
64.0
sub industryPharmaceuticalsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorOncologysectoruk riosectorDrug DevelopmentsectorGenetics and genomicssectorSpinoutsectorGenome EngineeringsectorTech for Biotech and Pharmasectoruk is8 digital and technologiessectoruk is8 life sciences

Valuation & funding

PhoreMost funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Sep 2024 $12M $230M Amadeus Capital Partners · Astellas Venture · Parkwalk Advisors · Business Growth Fund
SERIES BOther financing Mar 2021 $46M $184M Morningside · Astellas Venture · O2h Ventures · Business Growth Fund
SERIES AOther financing May 2018 $15M $60M Amadeus Capital Partners · Jonathan Milner · 5Y Capital · Cambridge Enterprise
GRANTOther financing Jan 2017 $832K Undisclosed
SEEDOther financing Mar 2015 $3.8M $15M Jonathan Milner · Sunil Shah · Prashant Shah · Parkwalk Advisors
SPINOUTOther financing Jan 2014 University of Cambridge
Showing 6 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthEBITDAMargin
2026 $2.1M 0% −$13M -647.5%
2025 $2.1M +49.6% −$13M -647.5%
2024 $1.4M -11.6% −$13M -968.9%
2023 $1.6M +55.3% −$13M -856.6%
2022 $1M +13% −$11M -1092.9%
2021 $895K +38.5% −$11M -1216.4%
2020 $647K −$6.7M -1036.4%
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

PhoreMost website traffic

Latest recorded traffic for PhoreMost is 160 monthly website visits, up 23.1% over the last three months. PhoreMost's team declined 2.9% over the past year.

Latest monthly visits160 3-month web change+23.1% 1-year team growth-2.9%
Monthly website visits102 observations · May 2017–Jun 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

PhoreMost compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

PhoreMost's talent

Book a demo to see the people
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

14 investors on PhoreMost's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 5 investors entered at this stage
Jonathan Milner
Sunil Shah
Prashant Shah
Parkwalk Advisors
Amadeus Capital Partners
Series A 8 investors entered at this stage
Cambridge Enterprise
5Y Capital
Business Growth Fund
Morningside
Astellas Venture
O2h Ventures
XtalPi
Trend Investment Group
Other known 1 additional known investor
University of Cambridge

Global footprint

Where PhoreMost has talent and traffic

Workforce by country
3 countries with
team presence
🇬🇧 United Kingdom86.2%
🇺🇸 United States10.3%
🇮🇹 Italy3.5%
3 countries shown

In the news

Latest news about PhoreMost

Recent press, funding announcements, and product moves mentioning PhoreMost — open to read from the original sources.

See all news

Market sentiment

What the market is saying about PhoreMost

An AI-synthesized read of the highest-engagement posts about PhoreMost on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PhoreMost’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.